Familial Cancer
ISSN 1389-9600 · Springer Science+Business Media · Netherlands · active 1962–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Familial Cancer a predatory journal?
Our screening does not flag Familial Cancer. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Familial Cancer indexed in Scopus or Web of Science?
Per our venue index, Familial Cancer appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Familial Cancer's impact?
Papers in Familial Cancer are cited about 2.2 times each within two years of publication, and Scimago places it in Q2, with an h-index of 81. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Familial Cancer open access?
We hold no reliable open-access classification for Familial Cancer. Check the journal's own site for its access model and any article processing charge.